Pohl Gudrun, Gaertner Jan
Department of Palliative Medicine, University Medical Centre, Göttingen, Germany.
Wien Med Wochenschr. 2009 Dec;159(23-24):571-6. doi: 10.1007/s10354-009-0725-1.
The reported prevalence of dyspnea in patients with various cancers ranges from 19% to 64%. For optimal clinical management of dyspnea in cancer patients, accurate diagnosis of the underlying cause and thorough understanding of the pathomechanisms of dyspnea seems mandatory. The clinical approach to a patient with advanced cancer and dyspnea should include adequate history taking, physical examination, and selected diagnostic investigations. These should be performed immediately to enable quick treatment decisions. In addition, self assessment of the intensity of dyspnea by the patient may help to assess patient's needs as soon as possible.
据报道,各类癌症患者中呼吸困难的患病率在19%至64%之间。为了对癌症患者的呼吸困难进行最佳临床管理,准确诊断潜在病因并深入了解呼吸困难的发病机制似乎是必不可少的。对于晚期癌症伴呼吸困难的患者,临床处理应包括详细的病史采集、体格检查以及选择合适的诊断性检查。这些检查应立即进行,以便迅速做出治疗决策。此外,患者对呼吸困难强度的自我评估可能有助于尽快评估患者的需求。